TY - STD TI - "Coronavirus Age, Sex, Demographics (COVID-19) - Worldometer". www.worldometers.info. UR - http://www.worldometers.info ID - ref1 ER - TY - STD TI - "Wuhan Coronavirus Death Rate - Worldometer". www.worldometers.info. UR - http://www.worldometers.info ID - ref2 ER - TY - STD TI - "Report 4: Severity of 2019-novel coronavirus (nCoV)"(PDF). ID - ref3 ER - TY - JOUR AU - Zhou, P. AU - Yang, X. L. AU - Wang, X. G. AU - Hu, B. AU - Zhang, L. AU - Zhang, W. PY - 2020 DA - 2020// TI - A pneumonia outbreak associated with a new coronavirus of probable bat origin JO - Nature. VL - 579 UR - https://doi.org/10.1038/s41586-020-2012-7 DO - 10.1038/s41586-020-2012-7 ID - Zhou2020 ER - TY - BOOK AU - Qin, C. AU - Zhou, L. AU - Hu, Z. AU - Zhang, S. AU - Yang, S. AU - Tao, Y. PY - 2020 DA - 2020// TI - Dysregulation of immune response in patients with COVID-19 in Wuhan PB - China CY - Clinical Infectious Diseases ID - Qin2020 ER - TY - JOUR AU - Arnon, R. AU - Sela, M. PY - 1999 DA - 1999// TI - The chemistry of the Copaxone drug JO - Chem. Isr. VL - 1 ID - Arnon1999 ER - TY - JOUR AU - Bar-Or, A. AU - Pachner, A. AU - Menguy-Vacheron, F. AU - Kaplan, J. AU - Wiendl, H. PY - 2014 DA - 2014// TI - Teriflunomide and its mechanism of action in multiple sclerosis JO - Drugs. VL - 74 UR - https://doi.org/10.1007/s40265-014-0212-x DO - 10.1007/s40265-014-0212-x ID - Bar-Or2014 ER - TY - JOUR AU - Kieseier, B. C. PY - 2011 DA - 2011// TI - The mechanism of action of interferon-β in relapsing multiple sclerosis JO - CNS Drugs. VL - 25 UR - https://doi.org/10.2165/11591110-000000000-00000 DO - 10.2165/11591110-000000000-00000 ID - Kieseier2011 ER - TY - JOUR AU - Brück, J. AU - Dringen, R. AU - Amasuno, A. AU - Pau-Charles, I. AU - Ghoreschi, K. PY - 2018 DA - 2018// TI - A review of the mechanisms of action of dimethylfumarate in the treatment of psoriasis JO - Exp Dermatol. VL - 27 UR - https://doi.org/10.1111/exd.13548 DO - 10.1111/exd.13548 ID - Brück2018 ER - TY - JOUR AU - Hutchinson, M. PY - 2007 DA - 2007// TI - Natalizumab: A new treatment for relapsing remitting multiple sclerosis JO - Ther Clin Risk Manag. VL - 3 UR - https://doi.org/10.2147/tcrm.2007.3.2.259 DO - 10.2147/tcrm.2007.3.2.259 ID - Hutchinson2007 ER - TY - JOUR AU - Chun, J. AU - Hartung, H. PY - 2010 DA - 2010// TI - Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis JO - Clinical Neuropharmacology. VL - 33 UR - https://doi.org/10.1097/WNF.0b013e3181cbf825 DO - 10.1097/WNF.0b013e3181cbf825 ID - Chun2010 ER - TY - JOUR AU - Ruck, T. AU - Bittner, S. AU - Wiendl, H. AU - Meuth, S. G. PY - 2015 DA - 2015// TI - Alemtuzumab in multiple sclerosis: mechanism of action and beyond JO - Int J Mol Sci. VL - 16 UR - https://doi.org/10.3390/ijms160716414 DO - 10.3390/ijms160716414 ID - Ruck2015 ER - TY - JOUR AU - Cerny, T. AU - Borisch, B. AU - Introna, M. AU - Johnson, P. AU - Rose, A. L. PY - 2002 DA - 2002// TI - Mechanism of action of rituximab JO - Anticancer Drugs. VL - 13 UR - https://doi.org/10.1097/00001813-200211002-00002 DO - 10.1097/00001813-200211002-00002 ID - Cerny2002 ER - TY - JOUR AU - Behrangi, N. AU - Fischbach, F. AU - Kipp, M. PY - 2019 DA - 2019// TI - Mechanism of siponimod: anti-inflammatory and neuroprotective mode of action JO - Cells VL - 8 UR - https://doi.org/10.3390/cells8010024 DO - 10.3390/cells8010024 ID - Behrangi2019 ER -